Articles By Anuja Singh
Will the US Health Agency Expand Coverage for GLP-1 Weight-Loss Drugs?
The U.S. Centers for Medicare & Medicaid Services (CMS) announced a new voluntary program to expand coverage of…
ByHow is Bristol Myers Squibb Driving Growth After 2025’s Strategic Recalibration?
Bristol Myers Squibb (BMS) continues to build momentum in its post-loss-of-exclusivity strategy, with 2025 marked as a year…
Will Agios Pharma’s FDA Approval Expansion Drive a New Growth Phase in Blood Disorder…
Cambridge, Massachusetts | December 26, 2025 Agios Pharmaceuticals announced a major regulatory milestone after the U.S. Food and…
Novartis Builds on a Track Record of Expansion Ahead of the 2026 J.P. Morgan…
Basel, Switzerland Novartis closed 2025 with sustained operational momentum, building on its transformation into a pure-play innovative medicines…
Regeneron to Present at 44th Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including Regained Strength and Extended Survival
Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical Association (JAMA) Neurology…
Will the US Health Agency Expand Coverage for GLP-1 Weight-Loss Drugs?
The U.S. Centers for Medicare & Medicaid Services (CMS) announced a new voluntary program to expand coverage of…
How is Bristol Myers Squibb Driving Growth After 2025’s Strategic Recalibration?
Bristol Myers Squibb (BMS) continues to build momentum in its post-loss-of-exclusivity strategy, with 2025 marked as a year…
Will Agios Pharma’s FDA Approval Expansion Drive a New Growth Phase in Blood Disorder…
Cambridge, Massachusetts | December 26, 2025 Agios Pharmaceuticals announced a major regulatory milestone after the U.S. Food and…
Novartis Builds on a Track Record of Expansion Ahead of the 2026 J.P. Morgan…
Basel, Switzerland Novartis closed 2025 with sustained operational momentum, building on its transformation into a pure-play innovative medicines…
Regeneron to Present at 44th Annual J.P. Morgan Healthcare Conference
TARRYTOWN, N.Y. – Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will webcast its presentation at the…
QALSODY® Shows Long-Term Benefits for SOD1-ALS Patients, Including Regained Strength and Extended Survival
Cambridge, Mass. Biogen Inc. (Nasdaq: BIIB) today announced that The Journal of the American Medical Association (JAMA) Neurology…